Immunogen (IMGN) Posts Q4 Loss of 71c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cantor Fitzgerald Downgrades Immunogen Inc. (IMGN) to Hold
August 3, 2015 6:43 AM EDTCantor Fitzgerald downgraded Immunogen Inc. (NASDAQ: IMGN) from Buy to Hold with a price target of $21.00 (from $12.00) on valuation.
Analyst Mara Goldstein commented, "We are downgrading ImmunoGen shares to HOLD from BUY, and raising our PT to $21 from $12. Our PT raise reflects... More
Immunogen (IMGN) PT Raised to $24 at Oppenheimer Ahead of '853 Path Forward
July 29, 2015 8:33 AM EDTOppenheimer analyst Christopher Marai reiterated an Outperform rating and raised his price target on Immunogen Inc. (NASDAQ: IMGN) to $24.00 (from $13.00) in anticipation of clarity on '853's path forward and updated data by
YE15. We also anticipate these updates, potentially on Friday's... More
